1. Home
  2. HLP vs GOSS Comparison

HLP vs GOSS Comparison

Compare HLP & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hongli Group Inc.

HLP

Hongli Group Inc.

HOLD

Current Price

$2.02

Market Cap

92.7M

Sector

Industrials

ML Signal

HOLD

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$12.10

Market Cap

83.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLP
GOSS
Founded
2021
2015
Country
China
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
92.7M
83.2M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
HLP
GOSS
Price
$2.02
$12.10
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
$4.19
AVG Volume (30 Days)
111.5K
12.9M
Earning Date
05-08-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$48,471,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$201.64
P/E Ratio
$51.63
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.34
$0.11
52 Week High
$2.12
$12.52

Technical Indicators

Market Signals
Indicator
HLP
GOSS
Relative Strength Index (RSI) 77.34 96.52
Support Level $1.10 $0.18
Resistance Level N/A $12.52
Average True Range (ATR) 0.16 0.51
MACD 0.07 1.27
Stochastic Oscillator 90.71 98.02

Price Performance

Historical Comparison
HLP
GOSS

About HLP Hongli Group Inc.

Hongli Group Inc is an offshore holding company. Through its subsidiaries, it is engaged in the cold-rolled steel profile manufacturing in China. Its main business operation focuses on the design, production, deep processing, and sales of custom-made profiles for machinery and equipment in a variety of sectors, including but not limited to mining and excavation, construction, agriculture, and transportation industries. The group operates in a single segment, which manufactures and sells agricultural machinery cab assemblies, construction machinery cab assemblies, excavator cab assemblies, and special-shaped steel pipes. It generates the majority of its reveneue from PRC.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).

Share on Social Networks: